<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR23">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Johnson</surname>
    <given-names>FM</given-names>
   </name>
   <name>
    <surname>Agrawal</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Burris</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Rosen</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Dhillon</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>D</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 1 pharmacokinetic and drug‚Äêinteraction study of dasatinib in patients with advanced solid tumors</article-title>
  <source>Cancer</source>
  <year>2010</year>
  <volume>116</volume>
  <fpage>1582</fpage>
  <lpage>91</lpage>
  <pub-id pub-id-type="doi">10.1002/cncr.24927</pub-id>
  <?supplied-pmid 20108303?>
  <pub-id pub-id-type="pmid">20108303</pub-id>
 </element-citation>
</ref>
